Netherlands Cardiovascular Devices Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook 2026-2030

The Netherlands cardiovascular devices market reached approximately €686.27 million in 2025, representing a specialized yet dynamic segment of the country's total medical device market, which is valued at around EUR 3.2 billion and growing at a 5.5% CAGR. Within the broader European context, the region's cardiovascular devices market stands at $21.1 billion, with the Netherlands capturing a meaningful share driven by its advanced healthcare infrastructure and high prevalence of circulatory diseases.

• •Market valued at approximately €686.27 million ($0.72 billion) in 2025 with a projected 5.58% CAGR through 2033
• •Total Dutch medical device market stands at EUR 3.2 billion in 2025, with cardiovascular and interventional devices among the top in-demand categories
• •Europe-wide cardiovascular devices market reached $21.1 billion in 2025, reflecting strong regional demand

An aging demographic profile in the Netherlands has increased the burden of chronic cardiovascular conditions, particularly heart failure and coronary artery disease, directly expanding the patient population requiring cardiac device interventions. The shift toward minimally invasive procedures, including transcatheter therapies and interventional cardiology techniques, has broadened the addressable market by enabling treatment for patients previously considered high-risk surgical candidates.

• •Aging population driving increased prevalence of heart failure, coronary artery disease, and cardiac arrhythmia
• •Rising adoption of transcatheter therapies and minimally invasive procedures across interventional cardiology
• •High circulatory disease mortality rates accelerating demand for therapeutic and monitoring devices

The Netherlands market encompasses device categories including cardiac rhythm management, interventional cardiology, cardiac surgery devices, and rapidly growing wearable cardiac monitors such as smartwatches, patches, and holter monitors. Hospitals constitute the primary end-user segment, with strong demand for therapeutic and surgical devices, while the broader Europe wearable cardiac devices segment alone reached $591.7 million in 2025, reflecting regional technological adoption trends.

• •Hospitals are the dominant end-user segment, with strong demand for therapeutic and surgical devices targeting arrhythmia and heart failure
• •Wearable cardiac devices (smartwatches, patches, holter monitors) represent a growing sub-market, with Europe reaching $591.7 million in 2025
• •Device categories span cardiac rhythm management, interventional cardiology, cardiac surgery, and diagnostic monitoring systems

What are the recent trends and outlook?

The market is expected to sustain its growth trajectory through 2033, supported by continued demographic shifts, rising healthcare expenditures, and ongoing clinical adoption of advanced interventional techniques. Innovation in wearable cardiac monitoring and remote patient management technologies is anticipated to open new market avenues, while hospitals and specialty clinics will remain the primary demand centers for high-complexity cardiac device procedures.

• •Continued growth expected through 2033 at a 5.58% CAGR, supported by rising healthcare expenditures
• •Wearable cardiac monitoring and remote patient management technologies poised for accelerated adoption
• •Transcatheter and minimally invasive procedures projected to drive volume growth across interventional cardiology and cardiac surgery segments